 |
|
New device finds early signs of eye disease in preemies
September 22, 2009DURHAM, N.C. -- Tell-tale signs of a condition that can blind premature babies are being seen for the first time using a new handheld device in a study at Duke University Medical Center.
The technology, developed in part by Duke biomedical engineers, uses spectral domain optical coherence tomography (SD OCT) to create a 3-D picture of the back of the eye. "This new tool is changing the way we identify eye conditions in infants," says Cynthia Toth, MD, an ophthalmologist at the Duke Eye Center, who is leading the study that appears online this month in the journal Ophthalmology.
Retinopathy of prematurity (ROP) is one of the most common causes of vision loss in children, affecting about 16,000 babies each year, according to the National Eye Institute. It occurs when babies are born prematurely and their retinal blood vessels don't develop fully. Instead, the vessels grow abnormally and are prone to leaking and contracting. That can pull the retina out of position, causing retinal detachments that can lead to visual loss and blindness.
Current screening for ROP is based on two-dimensional images taken either with an ophthalmoscope or a camera placed directly on the infant's cornea. "Examining the retina with these methods is like looking at the surface of the ocean and only seeing dimly into the shallow water," says Toth, a professor of ophthalmology and biomedical engineering. "You cannot see what lies below."
SD OCT, on the other hand, uses a narrow beam of light to create a 3-D high-resolution map of the intricate detail in the retina's layers. "This is like looking into an aquarium from the side, where all the fish at every depth are visible," Toth says.
Ophthalmologists at Duke Eye Center pioneered and have been using OCT to accurately diagnose adult eyes for more than a decade, and in the past two years, Toth has been studying the application of this technology for retinal diseases in children.
"SD OCT reveals the retina in greater detail than was ever before realized, allowing us to observe disease at almost the cellular level" she says.
New advances in OCT led Joseph Izatt, a professor of biomedical engineering and ophthalmology at Duke, to create the handheld probe which can snap pictures over 40 times faster than previous versions of OCT. That means multiple scans of the eye now take only seconds. It also means the portable handheld SD OCT system can be taken directly to premature infants in the incubator.
The device is manufactured by Bioptigen, Inc., a Duke spinout company in Research Triangle Park. Izatt is the chairman and chief technology officer of the firm.
"Now, for the first time, we can take the SD OCT system into the neonatal intensive care unit and hold it over the infant's eye without touching the eye and image the retina while the infant is lying in the bed," she says. "We don't have to transport the infants out of the intensive care unit, which makes the whole process much more comfortable for them and their parents."
Toth's next step is to determine what role the system could play in treatment decisions.
"Right now we're analyzing data on more than 20 infants to identify how the SC OCT images of RoP relate to the usual examination and to decisions we make about treatment. What we hope to learn is whether what we see in the infant's eyes today will help us to predict how their disease and vision will be in the future."
Toth says this imaging technology could also have practical applications for improving the diagnosis and treatment of babies suspected of having a wide range of retinal diseases including albinism and retinal injury.
Duke University Medical Center
Current screening for ROP is based on two-dimensional images taken either with an ophthalmoscope or a camera placed directly on the infant's cornea. "Examining the retina with these methods is like looking at the surface of the ocean and only seeing dimly into the shallow water," says Toth, a professor of ophthalmology and biomedical engineering. "You cannot see what lies below."
SD OCT, on the other hand, uses a narrow beam of light to create a 3-D high-resolution map of the intricate detail in the retina's layers. "This is like looking into an aquarium from the side, where all the fish at every depth are visible," Toth says.
Ophthalmologists at Duke Eye Center pioneered and have been using OCT to accurately diagnose adult eyes for more than a decade, and in the past two years, Toth has been studying the application of this technology for retinal diseases in children.
"SD OCT reveals the retina in greater detail than was ever before realized, allowing us to observe disease at almost the cellular level" she says.
New advances in OCT led Joseph Izatt, a professor of biomedical engineering and ophthalmology at Duke, to create the handheld probe which can snap pictures over 40 times faster than previous versions of OCT. That means multiple scans of the eye now take only seconds. It also means the portable handheld SD OCT system can be taken directly to premature infants in the incubator.
The device is manufactured by Bioptigen, Inc., a Duke spinout company in Research Triangle Park. Izatt is the chairman and chief technology officer of the firm.
"Now, for the first time, we can take the SD OCT system into the neonatal intensive care unit and hold it over the infant's eye without touching the eye and image the retina while the infant is lying in the bed," she says. "We don't have to transport the infants out of the intensive care unit, which makes the whole process much more comfortable for them and their parents."
Toth's next step is to determine what role the system could play in treatment decisions.
"Right now we're analyzing data on more than 20 infants to identify how the SC OCT images of RoP relate to the usual examination and to decisions we make about treatment. What we hope to learn is whether what we see in the infant's eyes today will help us to predict how their disease and vision will be in the future."
Toth says this imaging technology could also have practical applications for improving the diagnosis and treatment of babies suspected of having a wide range of retinal diseases including albinism and retinal injury.
Duke University Medical Center
Retinal Diseases Current Events and Retinal Diseases News RSS1 shot of gene therapy and children with congenital blindness can now see
Born with a retinal disease that made him legally blind, and would eventually leave him totally sightless, the nine-year-old boy used to sit in the back of the classroom, relying on the large print on an electronic screen and assisted by teacher aides.
First in New York: Bionic technology aims to give sight to woman blinded beginning at age 13
A 50-year-old New York woman who was diagnosed with a progressive blinding disease at age 13 was implanted with an experimental electronic eye implant that has partially restored her vision.
Experimental treatments restore partial vision to blind people
Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health, may lead to new treatments for the blind.
Anti-growth factor drugs raise hope and concern for treatment of children's eye diseases
A new class of antibody drugs may provide a powerful new tool for the treatment of eye diseases in children, but specialists need to be alert for the possibility of serious side effects, according to an editorial in the August Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus), published by Elsevier.
UF scientists program blood stem cells to become vision cells
University of Florida researchers were able to program bone marrow stem cells to repair damaged retinas in mice, suggesting a potential treatment for one of the most common causes of vision loss in older people.
Mutated gene in zebrafish sheds light on blindness in humans
Among zebrafish, the eyes have it. Inside them is a mosaic of light-sensitive cells whose structure and functions are nearly identical to those of humans.
ORNL, UT project could save vision of millions
In the blink of an eye, people at risk of becoming blind can now be screened for eye diseases such as diabetic retinopathy and age-related macular degeneration.
Conference report highlights new research into drug delivery to treat eye disease
Researchers are investigating microneedles, nanoparticles and polymer carriers as potential new techniques to combat the leading cause of visual impairment and blindness in the United States, according to a report from the Third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.
Vision loss more common in people with diabetes
Visual impairment appears to be more common in people with diabetes than in those without the disease, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Gene therapy improves vision in patients with congenital retinal disease
In a clinical trial at The Children's Hospital of Philadelphia, researchers from The University of Pennsylvania have used gene therapy to safely restore vision in three young adults with a rare form of congenital blindness.
More Retinal Diseases Current Events and Retinal Diseases News Articles
 |
Retinal Vascular Disease by A.M. Joussen (Editor), T.W. Gardner (Editor), B. Kirchhof (Editor), S.J. Ryan (Editor) Vascular diseases of the retina are a major cause of blindness among all age groups. Edited and written by internationally well-known experts, this state-of-the-art comprehensive overview of basic and clinical science will enhance the understanding of retinal vascular disease and help in the evaluation of current and future treatment approaches for the clinician. The well-structured and highly illustrated text is divided into the following three main sections: |
![Health Talks at The Cleveland Clinic Presents - Advances in Macular and Retinal Diseases [VHS]](http://ecx.images-amazon.com/images/I/41A0ECT27TL._SL160_.jpg) |
Health Talks at The Cleveland Clinic Presents - Advances in Macular and Retinal Diseases [VHS] |
 |
Jarrow Formulations Jarrow Ginkgo Biloba 60mg Twinpack, 60+60 Capsules by Jarrow Formulations This product contains GinkgoSelect? which is produced by a patented, multi-phase extraction process resulting in a standardized 24% ginkgoflavonglycoside (or heteroside) and a minimum of 6% terpene lactone extract. Ginkgolides A and B are the most active fractions. Ginkgo Biloba has a wide range of beneficial effects, including circulatory and antioxidant protection.* |
 |
Retinal Angiography and Optical Coherence Tomography by J. Fernando Arevalo (Editor) OCT is a relatively new imaging technique that is becoming increasingly popular among ophthalmologists in both private and academic settings. Imaging has been a slow moving area in ophthalmology for some time, but now OCT is providing another, more detailed source of demonstrable change in the eye, in diagnostic, therapeutic or post-surgical setting. OCT and ultrasound both measure advancing disease states and post surgical healing. The difference is that OCT shows more subtle changes, particularly post-surgically. |
 |
Handbook of Pediatric Retinal Disease (Springer Handbook of) by Kenneth W. Wright (Editor), Peter H. Spiegel (Editor), Lisa Thompson (Editor), T.C. Hengst (Editor), S. Gilbert (Editor), F. Cogswell (Editor) Based on Dr. Wright’s classic major reference, Handbook of Pediatric Retinal Disease outlines the latest findings in diagnosing retinal disorders in children's and the best available treatment options. Distilling the essentials of these somewhat uncommon discorders and diseases into a portable, complete and authorative pocket reference, this handbook offers a complete picture of how to best treat pediatric patients. Specifically, the introductory chapters on the specifics of pediatric ophthalmology (embryology, post-natal development and the pediatric exam) will help newcomers to pediatric practice fully grasp the subtle differences in pediatric care. The chapters are written by leading experts in the field and are presented in a user-friendly format, relying on heavily illustrated in... |
 |
Optical Coherence Tomography in Retinal Disease by Sandeep Saxena (Author) A complete summary of everything currently known about the use of Optical Coherence Tomography in managing diseases of the retina Edited by two world-renowned ophthalmologists, Optical Coherence Tomography in Retinal Disease offers the priceless insights and expertise of leading international practitioners of OCT in both the medical and surgical areas of ophthalmology. Meticulous, authoritative guidance: Includes vital information on the interpretation and uses of OCT and about the actual equipment used Features contributions from international authorities in both the medical and surgical subdivisions of ophthalmology Provides details for using OCT with a range of retinal disorders Incorporates more than 1,100... |
 |
Ginkgo Biloba Extract 60mg Twinpack 120 Capsules by Olympian Labs Ginkgo Biloba is a tree that is living proof to longevity and vitality. The Ginkgo Biloba tree is naturally resistant to disease, insects and pollution and has a life span of two to four thousand years! Though it yields an edible almond shaped white seed, the medicinal powers are found in the leaves of this special tree. Research has shown that Ginkgo Biloba may improve the circulation of oxygen, act as a free radical scavenger and improve nerve cell functioning and nerve cell transmission. This translates to improvements in memory and mental efficiency, and treatments for disorders like Raynauds (a blood vessel disorder) and Alzheimers disease. Its anti-oxidant action may aid the body in preventing the onset of illness and disease. |
|
Optical Coherence Tomography Retinal Diseases - Glaucoma by George P. Theodossiadis (Author) | |
 |
Retinal Degenerative Diseases (Advances in Experimental Medicine and Biology) by Joe G. Hollyfield (Editor), Robert E. Anderson (Editor), Matthew M. LaVail (Editor) Retinal Degenerations is the result of the International Symposium on Retinal degeneration which has become perhaps the most important research meeting in the field. THe topics in this volume explore the etiology, cellular mechanisms, epidemiology, genetics, models and potential therapeutic measures for the blinding diseases of retinitis pigmentosa and age-related macular degeneration. |
 |
Solaray - Ginkgo Biloba Extract 60 mg 60 Vcp by Solaray Solaray Guaranteed Potency Herbs deliver confidence by providing exact and consistent amounts of herbs of the highest quality available. Solaray Ginkgo Biloba meets European standards and includes all important compounds including ginkgolides and bilobalide. |
| © 2009 BrightSurf.com |